Literature DB >> 17279553

Insulin-like growth factor-I ameliorates demyelination induced by tumor necrosis factor-alpha in transgenic mice.

Ping Ye1, George Kollias, A Joseph D'Ercole.   

Abstract

Our groups have reported that tumor necrosis factor-alpha (TNF-alpha) causes myelin damage and apoptosis of oligodendrocytes and their precursors in vitro and in vivo. We also have reported that insulin-like growth factor-I (IGF-I) can protect cultured oligodendrocytes and their precursors from TNF-alpha-induced damage. In this study, we investigated whether IGF-I can protect oligodendrocytes and myelination from TNF-alpha-induced damage in vivo by cross-breeding TNF-alpha transgenic (Tg) mice with IGF-I Tg mice that overexpress IGF-I exclusively in brain. At 8 weeks of age, compared with those of wild-type (WT) mice, the brain weights of TNF-alpha Tg mice were decreased by approximately 20%, and those of IGF-I Tg mice were increased by approximately 20%. The brain weights of mice that carry both TNF-alpha and IGF-I transgenes (TNF-alpha/IGF-I Tg mice) did not differ from those of WT mice. As judged by histochemical staining and immunostaining, myelin content in the cerebellum of TNF-alpha/IGF-I Tg mice was similar to that in WT mice and much more than that in TNF-alpha Tg mice. Consistently, Western immunoblot analysis showed that myelin basic protein (MBP) abundance in the cerebellum of TNF-alpha/IGF-I Tg mice was double that in TNF-alpha Tg mice. In comparison with WT mice, the number of oligodendrocytes was decreased by approximately 36% in TNF-alpha Tg mice, whereas it was increased in IGF-I Tg mice by approximately 40%. Oligodendrocyte number in TNF-alpha/IGF-I Tg mice was almost twice that in TNF-alpha Tg mice. Furthermore, IGF-I overexpression significantly reduced TNF-alpha-induced increases in apoptotic cell number, active caspase-3 abundance, and degradaion of MBP. Our results indicate that IGF-I is capable of protecting myelin and oligodendrocytes from TNF-alpha-induced damage in vivo.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17279553      PMCID: PMC1832145          DOI: 10.1002/jnr.21181

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  31 in total

1.  Insulin-like growth factor-I (IGF-I) protects myelination from undernutritional insult: studies of transgenic mice overexpressing IGF-I in brain.

Authors:  P Ye; K H Lee; A J D'Ercole
Journal:  J Neurosci Res       Date:  2000-12-01       Impact factor: 4.164

2.  Insulin-like growth factor-1 inhibits mature oligodendrocyte apoptosis during primary demyelination.

Authors:  J L Mason; P Ye; K Suzuki; A J D'Ercole; G K Matsushima
Journal:  J Neurosci       Date:  2000-08-01       Impact factor: 6.167

3.  Effect of tumor necrosis factor-alpha on developing optic nerve oligodendrocytes in culture.

Authors:  Yi Pang; Zhengwei Cai; Philip G Rhodes
Journal:  J Neurosci Res       Date:  2005-04-15       Impact factor: 4.164

4.  Insulin-like growth factor I protects oligodendrocytes from tumor necrosis factor-alpha-induced injury.

Authors:  P Ye; A J D'Ercole
Journal:  Endocrinology       Date:  1999-07       Impact factor: 4.736

5.  Effect of fasting on insulin-like growth factor (IGF)-IA and IGF-IB messenger ribonucleic acids and prehormones in rat liver.

Authors:  J Zhang; R E Whitehead; L E Underwood
Journal:  Endocrinology       Date:  1997-08       Impact factor: 4.736

6.  Insulin-like growth factor-I influences the initiation of myelination: studies of the anterior commissure of transgenic mice.

Authors:  P Ye; J Carson; A J D'Ercole
Journal:  Neurosci Lett       Date:  1995-12-15       Impact factor: 3.046

7.  Insulin-like growth factor I (IGF-I) regulates IGF binding protein-5 gene expression in the brain.

Authors:  P Ye; J D'Ercole
Journal:  Endocrinology       Date:  1998-01       Impact factor: 4.736

8.  Myelination is altered in insulin-like growth factor-I null mutant mice.

Authors:  Ping Ye; Liqin Li; R Gregg Richards; Richard P DiAugustine; A Joseph D'Ercole
Journal:  J Neurosci       Date:  2002-07-15       Impact factor: 6.167

9.  Insulin-like growth factor I treatment reduces demyelination and up-regulates gene expression of myelin-related proteins in experimental autoimmune encephalomyelitis.

Authors:  D L Yao; X Liu; L D Hudson; H D Webster
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-20       Impact factor: 11.205

10.  Insulin-like growth factor I gene expression is induced in astrocytes during experimental demyelination.

Authors:  S Komoly; L D Hudson; H D Webster; C A Bondy
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-01       Impact factor: 11.205

View more
  18 in total

Review 1.  Neurodevelopmental effects of insulin-like growth factor signaling.

Authors:  John O'Kusky; Ping Ye
Journal:  Front Neuroendocrinol       Date:  2012-06-16       Impact factor: 8.606

2.  Differential Sphingolipid and Phospholipid Profiles in Alcohol and Nicotine-Derived Nitrosamine Ketone-Associated White Matter Degeneration.

Authors:  Emine B Yalcin; Kavin Nunez; Ming Tong; Suzanne M de la Monte
Journal:  Alcohol Clin Exp Res       Date:  2015-12       Impact factor: 3.455

Review 3.  Extracellular cues influencing oligodendrocyte differentiation and (re)myelination.

Authors:  Natalie A Wheeler; Babette Fuss
Journal:  Exp Neurol       Date:  2016-03-23       Impact factor: 5.330

Review 4.  Insulin resistance and neurodegeneration: roles of obesity, type 2 diabetes mellitus and non-alcoholic steatohepatitis.

Authors:  Suzanne M de la Monte; Lisa Longato; Ming Tong; Jack R Wands
Journal:  Curr Opin Investig Drugs       Date:  2009-10

Review 5.  Exercise and brain health--implications for multiple sclerosis: Part 1--neuronal growth factors.

Authors:  Lesley J White; Vanessa Castellano
Journal:  Sports Med       Date:  2008       Impact factor: 11.136

Review 6.  Insulin-like growth factor system regulates oligodendroglial cell behavior: therapeutic potential in CNS.

Authors:  Daniel Chesik; Jacques De Keyser; Nadine Wilczak
Journal:  J Mol Neurosci       Date:  2008-02-26       Impact factor: 3.444

Review 7.  Lame ducks or fierce creatures? The role of oligodendrocytes in multiple sclerosis.

Authors:  T Zeis; N Schaeren-Wiemers
Journal:  J Mol Neurosci       Date:  2008-02-16       Impact factor: 3.444

8.  Signaling mechanisms regulating myelination in the central nervous system.

Authors:  Jared T Ahrendsen; Wendy Macklin
Journal:  Neurosci Bull       Date:  2013-04-05       Impact factor: 5.203

9.  Adult-onset deficiency in growth hormone and insulin-like growth factor-I alters oligodendrocyte turnover in the corpus callosum.

Authors:  Kun Hua; M Elizabeth Forbes; Robin J Lichtenwalner; William E Sonntag; David R Riddle
Journal:  Glia       Date:  2009-08-01       Impact factor: 7.452

Review 10.  The liver-brain axis of alcohol-mediated neurodegeneration: role of toxic lipids.

Authors:  Suzanne M de la Monte; Lisa Longato; Ming Tong; Sarah DeNucci; Jack R Wands
Journal:  Int J Environ Res Public Health       Date:  2009-07-23       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.